Emiglitate
Alternative Names: BAY O 1248; MKC 542Latest Information Update: 22 May 2001
At a glance
- Originator Bayer
- Developer Bayer; Mitsubishi Pharma Corporation
- Class Antihyperglycaemics; Benzoic acids; Imino pyranoses; Small molecules
- Mechanism of Action Alpha-glucosidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 22 May 2001 Profile reviewed but no significant changes made
- 01 Aug 1996 No-Development-Reported for Diabetes mellitus in Japan (PO)
- 02 Jun 1995 No-Development-Reported for Diabetes mellitus in Germany (PO)